Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diffusion Tensor Imaging | 12 | 2023 | 2390 | 1.550 |
Why?
|
Diffusion Magnetic Resonance Imaging | 10 | 2023 | 2783 | 0.880 |
Why?
|
Myocardium | 9 | 2020 | 4682 | 0.650 |
Why?
|
Heart Ventricles | 3 | 2020 | 3810 | 0.490 |
Why?
|
Heart | 5 | 2021 | 4393 | 0.480 |
Why?
|
Antiphospholipid Syndrome | 1 | 2015 | 165 | 0.450 |
Why?
|
Cardiac Imaging Techniques | 1 | 2015 | 275 | 0.430 |
Why?
|
Myofibrils | 1 | 2012 | 140 | 0.400 |
Why?
|
Cicatrix | 1 | 2018 | 782 | 0.400 |
Why?
|
Respiration | 3 | 2020 | 1647 | 0.380 |
Why?
|
Image Processing, Computer-Assisted | 6 | 2023 | 8976 | 0.360 |
Why?
|
Abortion, Spontaneous | 1 | 2015 | 527 | 0.350 |
Why?
|
Adenosine A2 Receptor Agonists | 1 | 2009 | 30 | 0.340 |
Why?
|
Thallium Radioisotopes | 1 | 2009 | 138 | 0.340 |
Why?
|
Technetium Tc 99m Sestamibi | 1 | 2009 | 173 | 0.330 |
Why?
|
Vasodilator Agents | 3 | 2009 | 975 | 0.320 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 2 | 2011 | 1069 | 0.300 |
Why?
|
Myocardial Infarction | 5 | 2018 | 11876 | 0.300 |
Why?
|
Myocardial Ischemia | 2 | 2015 | 2160 | 0.290 |
Why?
|
Myocardial Perfusion Imaging | 2 | 2011 | 568 | 0.290 |
Why?
|
Image Enhancement | 2 | 2015 | 2892 | 0.290 |
Why?
|
Natriuretic Peptide, C-Type | 4 | 2008 | 18 | 0.270 |
Why?
|
Brain Diseases | 1 | 2015 | 1539 | 0.270 |
Why?
|
Purines | 1 | 2009 | 602 | 0.270 |
Why?
|
Coronary Stenosis | 2 | 2009 | 819 | 0.250 |
Why?
|
Anisotropy | 4 | 2016 | 1289 | 0.240 |
Why?
|
Ventricular Remodeling | 1 | 2012 | 1249 | 0.240 |
Why?
|
Artifacts | 2 | 2023 | 1896 | 0.240 |
Why?
|
Adenosine | 1 | 2009 | 827 | 0.240 |
Why?
|
Blood Flow Velocity | 2 | 2009 | 1372 | 0.230 |
Why?
|
Coronary Circulation | 1 | 2009 | 1579 | 0.220 |
Why?
|
Cardiography, Impedance | 1 | 2003 | 40 | 0.220 |
Why?
|
Disease Models, Animal | 16 | 2018 | 18009 | 0.210 |
Why?
|
Radiopharmaceuticals | 2 | 2011 | 2683 | 0.210 |
Why?
|
Angioplasty, Balloon | 6 | 2008 | 610 | 0.200 |
Why?
|
Phantoms, Imaging | 4 | 2021 | 2501 | 0.200 |
Why?
|
Iliac Artery | 3 | 2002 | 345 | 0.190 |
Why?
|
Axons | 2 | 2019 | 1668 | 0.190 |
Why?
|
Blood Vessel Prosthesis Implantation | 4 | 2008 | 1416 | 0.180 |
Why?
|
Glioblastoma | 1 | 2016 | 3479 | 0.180 |
Why?
|
Swine | 20 | 2008 | 5893 | 0.180 |
Why?
|
Autophagy | 2 | 2022 | 1328 | 0.180 |
Why?
|
Echo-Planar Imaging | 4 | 2023 | 657 | 0.180 |
Why?
|
Models, Cardiovascular | 4 | 2004 | 971 | 0.170 |
Why?
|
Imaging, Three-Dimensional | 5 | 2023 | 4048 | 0.170 |
Why?
|
Models, Biological | 2 | 2016 | 9453 | 0.170 |
Why?
|
Chlorthalidone | 1 | 2019 | 21 | 0.170 |
Why?
|
Pyrazoles | 1 | 2009 | 1983 | 0.160 |
Why?
|
Renal Artery | 1 | 2001 | 366 | 0.160 |
Why?
|
Sodium Chloride Symporter Inhibitors | 1 | 2019 | 77 | 0.160 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2003 | 1491 | 0.160 |
Why?
|
Sheep, Domestic | 1 | 2018 | 50 | 0.150 |
Why?
|
Image Interpretation, Computer-Assisted | 4 | 2016 | 3351 | 0.150 |
Why?
|
Transfection | 8 | 2008 | 5781 | 0.150 |
Why?
|
Atrial Appendage | 1 | 2021 | 292 | 0.150 |
Why?
|
Blood Pressure | 6 | 2019 | 8500 | 0.140 |
Why?
|
Gene Transfer Techniques | 4 | 2008 | 1206 | 0.140 |
Why?
|
Femoral Artery | 5 | 2006 | 832 | 0.140 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2022 | 733 | 0.140 |
Why?
|
Blood Pressure Determination | 1 | 2001 | 637 | 0.140 |
Why?
|
Equipment Design | 3 | 2021 | 3525 | 0.140 |
Why?
|
Endocardium | 1 | 2018 | 250 | 0.140 |
Why?
|
Stents | 5 | 2008 | 3308 | 0.140 |
Why?
|
Aorta, Thoracic | 1 | 2003 | 1075 | 0.140 |
Why?
|
Radiation Dosage | 2 | 2015 | 1974 | 0.140 |
Why?
|
Brain Neoplasms | 2 | 2016 | 8917 | 0.140 |
Why?
|
Biomimetics | 1 | 2018 | 174 | 0.140 |
Why?
|
Monitoring, Intraoperative | 1 | 2003 | 940 | 0.140 |
Why?
|
Predictive Value of Tests | 5 | 2021 | 15228 | 0.130 |
Why?
|
Fluorescent Dyes | 2 | 2022 | 1914 | 0.130 |
Why?
|
Magnetic Resonance Imaging | 4 | 2022 | 36181 | 0.130 |
Why?
|
Brain | 7 | 2023 | 26883 | 0.130 |
Why?
|
Thrombosis | 3 | 2021 | 3033 | 0.130 |
Why?
|
Reproducibility of Results | 8 | 2021 | 20002 | 0.120 |
Why?
|
Corpus Callosum | 1 | 2019 | 744 | 0.120 |
Why?
|
Case-Control Studies | 3 | 2018 | 21917 | 0.110 |
Why?
|
Animals | 31 | 2022 | 167069 | 0.110 |
Why?
|
Arterial Occlusive Diseases | 5 | 2004 | 758 | 0.110 |
Why?
|
Molsidomine | 2 | 2002 | 22 | 0.110 |
Why?
|
Metabolic Clearance Rate | 2 | 2011 | 362 | 0.100 |
Why?
|
Cardiac-Gated Imaging Techniques | 1 | 2012 | 140 | 0.100 |
Why?
|
Biofeedback, Psychology | 1 | 2012 | 116 | 0.100 |
Why?
|
Plasmids | 6 | 2007 | 2276 | 0.100 |
Why?
|
Pulsatile Flow | 5 | 2004 | 320 | 0.090 |
Why?
|
Tomography | 1 | 2013 | 409 | 0.090 |
Why?
|
Nanoparticles | 1 | 2022 | 1918 | 0.090 |
Why?
|
Action Potentials | 1 | 2018 | 1794 | 0.090 |
Why?
|
Endothelial Growth Factors | 2 | 2002 | 673 | 0.090 |
Why?
|
Sheep | 1 | 2012 | 1437 | 0.090 |
Why?
|
Lymphokines | 2 | 2002 | 929 | 0.080 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2013 | 479 | 0.080 |
Why?
|
Endothelium, Vascular | 8 | 2008 | 4421 | 0.080 |
Why?
|
Clinical Protocols | 1 | 2015 | 1437 | 0.080 |
Why?
|
Receptor, Adenosine A2A | 1 | 2009 | 128 | 0.080 |
Why?
|
Antihypertensive Agents | 1 | 2019 | 2056 | 0.080 |
Why?
|
Tissue Distribution | 2 | 2011 | 2287 | 0.080 |
Why?
|
Hemodynamics | 4 | 2003 | 4185 | 0.080 |
Why?
|
Feasibility Studies | 2 | 2016 | 5180 | 0.080 |
Why?
|
Muscle, Smooth, Vascular | 4 | 2008 | 1484 | 0.080 |
Why?
|
Hyperemia | 1 | 2009 | 221 | 0.080 |
Why?
|
Gadolinium DTPA | 1 | 2011 | 826 | 0.080 |
Why?
|
Sirolimus | 2 | 2013 | 1534 | 0.080 |
Why?
|
Dogs | 2 | 2011 | 3843 | 0.080 |
Why?
|
Arteriosclerosis | 2 | 2002 | 1054 | 0.070 |
Why?
|
Analysis of Variance | 4 | 2011 | 6244 | 0.070 |
Why?
|
Subtraction Technique | 1 | 2011 | 519 | 0.070 |
Why?
|
Humans | 27 | 2023 | 756111 | 0.070 |
Why?
|
Movement | 1 | 2014 | 1474 | 0.070 |
Why?
|
Motion | 2 | 2021 | 785 | 0.070 |
Why?
|
Injections, Intravenous | 1 | 2009 | 1383 | 0.070 |
Why?
|
Hydrazones | 1 | 2007 | 101 | 0.070 |
Why?
|
Polylysine | 1 | 2007 | 131 | 0.070 |
Why?
|
Arteries | 4 | 2008 | 1115 | 0.070 |
Why?
|
Cyanoacrylates | 2 | 2005 | 46 | 0.070 |
Why?
|
Cerebral Veins | 1 | 2008 | 154 | 0.070 |
Why?
|
Cardiovascular Agents | 1 | 2013 | 865 | 0.070 |
Why?
|
Pseudotumor Cerebri | 1 | 2008 | 108 | 0.070 |
Why?
|
Bone Marrow Transplantation | 1 | 2014 | 2687 | 0.070 |
Why?
|
Mice, Inbred C57BL | 4 | 2018 | 21780 | 0.060 |
Why?
|
Models, Theoretical | 1 | 2018 | 3561 | 0.060 |
Why?
|
Pyridazines | 1 | 2007 | 201 | 0.060 |
Why?
|
Neovascularization, Physiologic | 2 | 2002 | 1334 | 0.060 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2002 | 1646 | 0.060 |
Why?
|
Natriuretic Agents | 1 | 2005 | 57 | 0.060 |
Why?
|
Anesthesia, Inhalation | 1 | 2006 | 219 | 0.060 |
Why?
|
Sensitivity and Specificity | 3 | 2015 | 14654 | 0.060 |
Why?
|
Infusions, Intravenous | 1 | 2009 | 2228 | 0.060 |
Why?
|
Acute Disease | 3 | 2011 | 7229 | 0.060 |
Why?
|
Embolization, Therapeutic | 2 | 2005 | 1402 | 0.060 |
Why?
|
Systole | 2 | 2019 | 948 | 0.060 |
Why?
|
Methyl Ethers | 1 | 2006 | 196 | 0.060 |
Why?
|
Cardiotonic Agents | 1 | 2007 | 547 | 0.060 |
Why?
|
Molecular Imaging | 1 | 2011 | 825 | 0.060 |
Why?
|
Renal Artery Obstruction | 1 | 2005 | 224 | 0.060 |
Why?
|
Carotid Artery, Common | 1 | 2004 | 177 | 0.060 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2012 | 1274 | 0.060 |
Why?
|
Liposomes | 5 | 2006 | 774 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 3686 | 0.060 |
Why?
|
Constriction | 1 | 2003 | 171 | 0.050 |
Why?
|
Enbucrilate | 1 | 2003 | 30 | 0.050 |
Why?
|
Intra-Aortic Balloon Pumping | 1 | 2004 | 226 | 0.050 |
Why?
|
Collateral Circulation | 1 | 2004 | 282 | 0.050 |
Why?
|
Heart-Assist Devices | 2 | 2004 | 1283 | 0.050 |
Why?
|
Vascular Resistance | 1 | 2006 | 931 | 0.050 |
Why?
|
Myocytes, Cardiac | 1 | 2011 | 1645 | 0.050 |
Why?
|
Carbocyanines | 1 | 2022 | 173 | 0.050 |
Why?
|
Nitric Oxide Donors | 1 | 2002 | 125 | 0.050 |
Why?
|
Postoperative Hemorrhage | 1 | 2005 | 420 | 0.050 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2007 | 617 | 0.050 |
Why?
|
Ventricular Function, Right | 1 | 2006 | 611 | 0.050 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2012 | 2129 | 0.050 |
Why?
|
Cathepsins | 1 | 2022 | 242 | 0.050 |
Why?
|
Stainless Steel | 1 | 2001 | 79 | 0.050 |
Why?
|
Macrolides | 1 | 2022 | 204 | 0.050 |
Why?
|
Drug-Eluting Stents | 1 | 2008 | 757 | 0.050 |
Why?
|
Graft Occlusion, Vascular | 1 | 2004 | 555 | 0.050 |
Why?
|
Anesthetics, Inhalation | 1 | 2006 | 574 | 0.050 |
Why?
|
Statistics, Nonparametric | 2 | 2003 | 2849 | 0.040 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2008 | 1880 | 0.040 |
Why?
|
Silicones | 1 | 2001 | 228 | 0.040 |
Why?
|
Aging | 1 | 2019 | 8595 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor A | 4 | 2004 | 3472 | 0.040 |
Why?
|
Ventricular Function, Left | 1 | 2012 | 3844 | 0.040 |
Why?
|
Ultrasonics | 1 | 2001 | 207 | 0.040 |
Why?
|
Carotid Arteries | 1 | 2004 | 951 | 0.040 |
Why?
|
Transducers | 1 | 2001 | 240 | 0.040 |
Why?
|
Coronary Restenosis | 1 | 2002 | 426 | 0.040 |
Why?
|
Time Factors | 7 | 2019 | 39991 | 0.040 |
Why?
|
Stress, Mechanical | 2 | 2002 | 1662 | 0.040 |
Why?
|
Female | 13 | 2021 | 388229 | 0.040 |
Why?
|
Elasticity | 1 | 2001 | 653 | 0.040 |
Why?
|
Fibrin | 1 | 2021 | 504 | 0.040 |
Why?
|
Hypertension | 1 | 2019 | 8532 | 0.040 |
Why?
|
Arginine | 1 | 2022 | 934 | 0.040 |
Why?
|
Coronary Vessels | 3 | 2004 | 3115 | 0.040 |
Why?
|
Models, Statistical | 1 | 2012 | 5062 | 0.040 |
Why?
|
Myocardial Contraction | 1 | 2003 | 1515 | 0.040 |
Why?
|
Cervical Vertebrae | 1 | 2023 | 976 | 0.040 |
Why?
|
Male | 14 | 2021 | 356852 | 0.040 |
Why?
|
Pulmonary Artery | 1 | 2006 | 1928 | 0.040 |
Why?
|
Adult | 7 | 2019 | 218302 | 0.040 |
Why?
|
Rats | 1 | 2012 | 23564 | 0.030 |
Why?
|
Computer Simulation | 2 | 2021 | 6190 | 0.030 |
Why?
|
Peripheral Vascular Diseases | 3 | 2004 | 516 | 0.030 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2005 | 1200 | 0.030 |
Why?
|
Polymers | 1 | 2003 | 1613 | 0.030 |
Why?
|
Doxorubicin | 1 | 2022 | 2196 | 0.030 |
Why?
|
Postoperative Care | 1 | 2002 | 1475 | 0.030 |
Why?
|
Spinal Cord | 1 | 2023 | 1808 | 0.030 |
Why?
|
Chronic Disease | 1 | 2009 | 9202 | 0.030 |
Why?
|
Tunica Intima | 2 | 2008 | 457 | 0.030 |
Why?
|
Pulmonary Embolism | 1 | 2007 | 2522 | 0.030 |
Why?
|
Sus scrofa | 2 | 2006 | 430 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2021 | 20421 | 0.030 |
Why?
|
Pregnancy | 1 | 2015 | 29548 | 0.030 |
Why?
|
DNA | 4 | 2011 | 7222 | 0.030 |
Why?
|
Radiography | 4 | 2008 | 6974 | 0.030 |
Why?
|
Constriction, Pathologic | 2 | 2008 | 1106 | 0.030 |
Why?
|
Glioma | 1 | 2008 | 3400 | 0.030 |
Why?
|
Ischemic Postconditioning | 1 | 2013 | 25 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2013 | 26034 | 0.030 |
Why?
|
Cells, Cultured | 5 | 2008 | 18929 | 0.030 |
Why?
|
Cathepsin B | 1 | 2013 | 80 | 0.030 |
Why?
|
Middle Aged | 7 | 2019 | 218357 | 0.030 |
Why?
|
Linear Models | 1 | 2003 | 5864 | 0.030 |
Why?
|
Microscopy, Electron, Scanning | 2 | 2005 | 945 | 0.030 |
Why?
|
Gene Expression | 4 | 2008 | 7582 | 0.030 |
Why?
|
Diastole | 1 | 2014 | 788 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2021 | 3759 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2002 | 2211 | 0.020 |
Why?
|
Models, Neurological | 1 | 2019 | 1757 | 0.020 |
Why?
|
Vascular Endothelial Growth Factors | 2 | 2002 | 749 | 0.020 |
Why?
|
Regional Blood Flow | 2 | 2004 | 1490 | 0.020 |
Why?
|
X-Ray Microtomography | 1 | 2013 | 432 | 0.020 |
Why?
|
Microspheres | 1 | 2013 | 786 | 0.020 |
Why?
|
Genetic Vectors | 3 | 2004 | 3363 | 0.020 |
Why?
|
Endothelial Cells | 3 | 2008 | 3506 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2013 | 1979 | 0.020 |
Why?
|
Mice | 4 | 2022 | 80709 | 0.020 |
Why?
|
Evans Blue | 1 | 2008 | 42 | 0.020 |
Why?
|
Cause of Death | 1 | 2019 | 3710 | 0.020 |
Why?
|
Coronary Disease | 1 | 2003 | 5994 | 0.020 |
Why?
|
Secondary Prevention | 2 | 2005 | 1547 | 0.020 |
Why?
|
Coronary Artery Disease | 1 | 2008 | 6625 | 0.020 |
Why?
|
Molecular Biology | 1 | 2011 | 579 | 0.020 |
Why?
|
Lysosomes | 1 | 2013 | 916 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2013 | 3600 | 0.020 |
Why?
|
Necrosis | 1 | 2011 | 1612 | 0.020 |
Why?
|
Cell Survival | 2 | 2008 | 5780 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2013 | 1974 | 0.020 |
Why?
|
Observer Variation | 1 | 2012 | 2596 | 0.020 |
Why?
|
Cations | 1 | 2007 | 238 | 0.020 |
Why?
|
Deoxyribonuclease I | 1 | 2007 | 223 | 0.020 |
Why?
|
Contrast Media | 2 | 2012 | 5305 | 0.020 |
Why?
|
Iodized Oil | 1 | 2005 | 10 | 0.020 |
Why?
|
Cell Death | 1 | 2011 | 1667 | 0.020 |
Why?
|
Fibrosis | 1 | 2012 | 2022 | 0.020 |
Why?
|
Manometry | 1 | 2008 | 448 | 0.020 |
Why?
|
Coloring Agents | 1 | 2008 | 560 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2021 | 6508 | 0.020 |
Why?
|
Follow-Up Studies | 4 | 2008 | 39187 | 0.020 |
Why?
|
Compliance | 1 | 2004 | 100 | 0.020 |
Why?
|
Cardiac Output | 1 | 2007 | 835 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2019 | 12353 | 0.020 |
Why?
|
Aged | 5 | 2019 | 167585 | 0.010 |
Why?
|
Receptors, Atrial Natriuretic Factor | 1 | 2004 | 43 | 0.010 |
Why?
|
Pulmonary Circulation | 1 | 2007 | 742 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2011 | 2663 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2022 | 7346 | 0.010 |
Why?
|
Aortography | 1 | 2005 | 420 | 0.010 |
Why?
|
Protein Sorting Signals | 1 | 2004 | 279 | 0.010 |
Why?
|
Injections, Intralesional | 1 | 2004 | 278 | 0.010 |
Why?
|
Heart Rate | 1 | 2014 | 4111 | 0.010 |
Why?
|
Injections, Intra-Arterial | 1 | 2003 | 182 | 0.010 |
Why?
|
Random Allocation | 1 | 2007 | 2389 | 0.010 |
Why?
|
Particle Size | 1 | 2007 | 1636 | 0.010 |
Why?
|
Binding Sites | 1 | 2011 | 6038 | 0.010 |
Why?
|
Angiogenic Proteins | 1 | 2003 | 101 | 0.010 |
Why?
|
Cerebral Angiography | 1 | 2008 | 1260 | 0.010 |
Why?
|
Angiography | 1 | 2008 | 1609 | 0.010 |
Why?
|
Foreign-Body Reaction | 1 | 2003 | 157 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2008 | 2936 | 0.010 |
Why?
|
Prevalence | 1 | 2019 | 15599 | 0.010 |
Why?
|
Angiography, Digital Subtraction | 1 | 2003 | 334 | 0.010 |
Why?
|
Introns | 1 | 2004 | 974 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 2002 | 872 | 0.010 |
Why?
|
Cell Proliferation | 2 | 2008 | 10382 | 0.010 |
Why?
|
Magnetic Resonance Angiography | 1 | 2008 | 1426 | 0.010 |
Why?
|
Software | 1 | 2015 | 4406 | 0.010 |
Why?
|
Arteritis | 1 | 2003 | 162 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2004 | 1991 | 0.010 |
Why?
|
Vascular Patency | 1 | 2004 | 903 | 0.010 |
Why?
|
Hemolysis | 1 | 2002 | 423 | 0.010 |
Why?
|
Paclitaxel | 1 | 2008 | 1704 | 0.010 |
Why?
|
Young Adult | 2 | 2019 | 58143 | 0.010 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2004 | 682 | 0.010 |
Why?
|
Prosthesis Failure | 1 | 2005 | 1215 | 0.010 |
Why?
|
Administration, Cutaneous | 1 | 2002 | 712 | 0.010 |
Why?
|
Drug Combinations | 1 | 2005 | 2010 | 0.010 |
Why?
|
Finite Element Analysis | 1 | 2002 | 429 | 0.010 |
Why?
|
Aorta | 1 | 2007 | 2037 | 0.010 |
Why?
|
Stroke Volume | 1 | 2012 | 5471 | 0.010 |
Why?
|
Genes, Reporter | 1 | 2002 | 1532 | 0.010 |
Why?
|
Models, Animal | 1 | 2004 | 2113 | 0.010 |
Why?
|
Cerebrovascular Circulation | 1 | 2008 | 2730 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2004 | 2361 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2008 | 2633 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2019 | 64582 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 23956 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 2003 | 3087 | 0.010 |
Why?
|
Risk Factors | 2 | 2019 | 73898 | 0.010 |
Why?
|
Apoptosis | 1 | 2013 | 9445 | 0.010 |
Why?
|
Cell Division | 1 | 2004 | 4448 | 0.010 |
Why?
|
Hypertension, Pulmonary | 1 | 2007 | 1561 | 0.010 |
Why?
|
Regeneration | 1 | 2005 | 1503 | 0.010 |
Why?
|
Lipids | 1 | 2007 | 3334 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2004 | 3725 | 0.010 |
Why?
|
Odds Ratio | 1 | 2008 | 9719 | 0.010 |
Why?
|
Prospective Studies | 2 | 2012 | 54040 | 0.010 |
Why?
|
Venous Thrombosis | 1 | 2004 | 1281 | 0.010 |
Why?
|
Base Sequence | 1 | 2006 | 12439 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2008 | 4093 | 0.010 |
Why?
|
Prosthesis Design | 1 | 2002 | 2125 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2008 | 11025 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2019 | 58608 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2006 | 10806 | 0.010 |
Why?
|
Wound Healing | 1 | 2004 | 2782 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2021 | 79746 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2004 | 5085 | 0.010 |
Why?
|
United States | 1 | 2019 | 71909 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2008 | 10256 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2002 | 8558 | 0.010 |
Why?
|
Incidence | 1 | 2008 | 21259 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2004 | 12755 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2004 | 16782 | 0.000 |
Why?
|